Baseline Metabolic Tumour Volume (MTV) as prognostic marker for forecasting Chemotherapy Outcome in Early-Stage Unfavourable Hodgkin Lymphoma: Data from the Phase III HD17 Trial
| Autor: | Roth, K., van Heek, L., Weindler, J., Gorniak, C., Kaul, H., Müller, H., Mettler, J., Baues, C., Fuchs, M., Borchmann, P., Ferdinandus, J., Dietlein, M., Voltin, C. A., Kobe, C. |
|---|---|
| Zdroj: | Nuklearmedizin. Nuclear medicine; March 2024, Vol. 63 Issue: 2 |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|